Article

Use of the Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs

2021-06-02

Abstract excerpt

Identifying anti-spike antibodies that exhibit strong neutralizing activity against current dominant circulating variants and antibodies that are escaped by these variants have important implications in the development of therapeutic and diagnostic solutions as well as in improving understanding of the humoral response to SARS-CoV-2 infection. We characterized seven anti-RBD monoclonal antibodies for their binding...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f42cab6a-fe0a-5cc3-a939-75eeed0c786b
DOI: 10.20944/preprints202106.0091.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Use of the Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDsDOI 10.20944/preprints202106.0091.v1Read

Novel, broad and potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesSemantic proximity Read

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacitySemantic proximity Read

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levelsSemantic proximity Read

Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variantsSemantic proximity Read

Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variantsSemantic proximity Read

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Semantic proximity Read

Structural Adaptability of IgA and IgM Supports Broad SARS-CoV-2 Variant Neutralization.Semantic proximity Read

Evaluation of a Rapid Semiquantitative Lateral Flow Assay for the Prediction of Serum Neutralizing Activity Against SARS-CoV-2 VariantsSemantic proximity Read

Development and Clinical Evaluation of a Rapid Antibody Lateral Flow Assay for the Diagnosis of SARS-CoV-2 InfectionSemantic proximity Read

Quantitative measurement of IgG to SARS-CoV-2 proteins using ImmunoCAPSemantic proximity Read

Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARDSemantic proximity Read

Homogeneous Surrogate Virus Neutralization Assay to Rapidly Assess Neutralization Activity of Anti-SARS-CoV-2 AntibodiesSemantic proximity Read